Press release
Veterinary CRO And CDMO Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Veterinary CRO And CDMO Market
The rise in investments towards animal healthcare is projected to amplify the progress of the veterinary CRO and CDMO market. This surge in investments is attributed to the increasing cognizance of animal health's significance and the broadening demand for veterinary services and products, all contributing to the market's expansion. For example, a report released by the American Pet Products Association (APPA), a non-profit organization in the US that advocates for pet ownership and the pet products industry, noted that pet care spending in the U.S. rose from USD 123.6 billion in 2021 to 136.8 billion in 2022, as per their October 2023 document. Consequently, these escalated investments in animal healthcare are set to bolster the growth of the veterinary CRO and CDMO market.
Get Your Veterinary CRO And CDMO Market Report Here:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report
What growth opportunities are expected to drive the veterinary cro and cdmo market's CAGR through 2034?
In recent times, the veterinary CRO and CDMO market has witnessed robust growth. The market size is forecasted to rise from $6.97 billion in 2024 to $7.55 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 8.3%. Factors such as the need for regulatory compliance, the global expansion of the animal health market, a spike in drug development for livestock, and more outsourcing by pharmaceutical companies have largely contributed to the growth during the historical period.
The market size of veterinary cro and cdmo is predicted to experience significant expansion in the upcoming years, escalating to a value of $10.74 billion by 2029 with a 9.2% compound annual growth rate (CAGR). This expected growth during the forecast period can be linked to the rising adoption of precision medicine, emphasis on preventive healthcare, epidemiology surveillance, readiness for emergencies, coupled with the growing complexity of veterinary therapeutics. Key trends that will define the forecast period include the outsourcing of research and development, technology integration, collaborations and partnerships, sustainability in manufacturing processes, and the digital transformation of veterinary services.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
What are the emerging trends shaping the future of the veterinary cro and cdmo market?
The focus on product advancement is a prominent trend in the veterinary CRO and CDMO market. To maintain their market standing, firms in the veterinary CRO and CDMO sectors are emphasizing on pioneering product development. In a recent development in June 2022, Vetio, an American Contract Development and Manufacturing Organization (CDMO) exclusively for animal healthcare, received an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) for its innovative Starch-Free Soft Chew tailored for veterinary use. The Soft Chew Technology by Vetio, particularly designed for animal care, is perfectly framed to deliver one or multiple active components in a high-standard dosage form apt for veterinary pharmaceutical application. The exceptional composition and production process of Vetio's invention is starch-free and does not contain extra water, making it extremely compatible for active ingredients that are sensitive to moisture.
Which growth-oriented segments of the veterinary cro and cdmo market are leading the industry's development?
The veterinary cro and cdmo market covered in this report is segmented -
1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications
Subsegments:
1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance
5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080
What regions are leading the charge in the veterinary cro and cdmo market?
North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the veterinary cro and cdmo market?
Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
What Is Covered In The Veterinary CRO And CDMO Global Market Report?
• Market Size Forecast: Examine the veterinary cro and cdmo market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the veterinary cro and cdmo market for a structured understanding.
• Key Players Overview: Analyze major players in the veterinary cro and cdmo market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the veterinary cro and cdmo market.
• Segment Contributions: Evaluate how different segments drive overall growth in the veterinary cro and cdmo market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the veterinary cro and cdmo market.
• Industry Challenges: Identify potential risks and obstacles affecting the veterinary cro and cdmo market.
• Competitive Landscape: Review strategic developments in the veterinary cro and cdmo market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Veterinary CRO And CDMO Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3898301 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for CRO
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues…
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money.
There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate…
